Evidence map›Paper›PMID 40787077›Full record

ArticleCrystal growth & design2025

Nonclassical Crystallization of the L‑Tartrate Salt of Cyamemazine.

Sreela Ramesh, Elina Harju, Teemu Tomberg, Jan Rohlíček, Eliška Zmeškalová, Thomas Rades, Clare J Strachan, Miroslav Šoóš

Abstract read
In one paragraph

Article in Crystal growth & design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sreela RameshDepartment of Chemical Engineering, University of Chemistry and Technology, Technická 3, Dejvice, 166 28 Prague 6, Czech Republic.
Elina HarjuDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790 Helsinki, Finland.ORCID https://orcid.org/0009-0009-3464-844X
Teemu TombergDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790 Helsinki, Finland.ORCID https://orcid.org/0000-0003-3448-2880
Jan RohlíčekDepartment of Structure Analysis, Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 112/10, 162 00 Praha 6, Czech Republic.
Eliška ZmeškalováDepartment of Chemical Engineering, University of Chemistry and Technology, Technická 3, Dejvice, 166 28 Prague 6, Czech Republic.
Thomas RadesDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-7521-6020
Clare J StrachanDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790 Helsinki, Finland.ORCID https://orcid.org/0000-0003-3134-8918
Miroslav ŠoóšDepartment of Chemical Engineering, University of Chemistry and Technology, Technická 3, Dejvice, 166 28 Prague 6, Czech Republic.ORCID https://orcid.org/0000-0002-9742-7160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the nonclassical crystallization of cyamemazine L-tartrate, a kryptoracemic salt of the antipsychotic drug cyamemazine. The crystallization pathway was studied via slurry conversion of a suspension of cyamemazine and L-tartaric acid in 2-propanol to the salt. Notably, the system transitioned through an intermediate droplet phase, which subsequently coalesced to form a dense phase. Both intermediate phases exhibited liquid crystalline character when observed under a polarized light microscope. The droplets demonstrated birefringence and a distinct Maltese cross extinction pattern, confirming their liquid crystalline nature. The dense phase revealed a fan-like texture when isolated and examined between glass slides. Comprehensive analyses of the intermediate droplet phase and the dense phase were conducted using solution

Identifiers

PMID40787077
PMCPMC12333587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.